Inquis Medical Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$75M
- Investors
-
8
Inquis Medical General Information
Description
Developer of a peripheral thrombectomy medical device designed to address unmet clinical needs and improve the standard of care. The company's technology focuses on improving the management of venous thromboembolic diseases and also offers an efficient single-pass thrombectomy with minimal blood loss, enabling clients to have medical devices that address unmet needs with a long-lasting impact.
Contact Information
Website
www.inquismedical.comCorporate Office
- 1530 O'Brien Drive
- Suite A
- Menlo Park, CA 94025
- United States
Corporate Office
- 1530 O'Brien Drive
- Suite A
- Menlo Park, CA 94025
- United States
Inquis Medical Timeline
Inquis Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 12-Jan-2026 | $75M | Completed | Clinical Trials - General | ||
| 3. Early Stage VC (Series B) | 28-Feb-2024 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | $18.4M | $26.4M | Completed | Stealth | ||
| 1. Seed Round | 19-Oct-2020 | $8M | $8M | Completed | Stealth |
Inquis Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 51,930,656 | $0.000010 | $0.35 | $0.35 | 1x | $0.35 | 11.86% | |
| Seed | 38,652,407 | $0.000010 | $0.02 | $0.2 | $0.2 | 1x | $0.2 | 8.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Inquis Medical Patents
Inquis Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025265146-A2 | Devices, systems, and methods for clot detection and removal | Pending | 21-Jun-2024 | ||
| WO-2025265146-A3 | Devices, systems, and methods for clot detection and removal | Pending | 21-Jun-2024 | ||
| US-20250339161-A1 | Apparatus for removing clot material | Pending | 06-May-2024 | ||
| US-20250339160-A1 | Methods for removing clot material from a patient | Pending | 06-May-2024 | ||
| WO-2025235560-A1 | Thrombectomy apparatuses and methods | Pending | 06-May-2024 | A61B17/22 |
Inquis Medical Signals
Inquis Medical Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| En Pointe | Venture Capital | Minority | ||
| Marshall Wace | Hedge Fund | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Junson Capital | Asset Manager | Minority |
Inquis Medical FAQs
-
When was Inquis Medical founded?
Inquis Medical was founded in 2020.
-
Where is Inquis Medical headquartered?
Inquis Medical is headquartered in Menlo Park, CA.
-
What is the size of Inquis Medical?
Inquis Medical has 49 total employees.
-
What industry is Inquis Medical in?
Inquis Medical’s primary industry is Therapeutic Devices.
-
Is Inquis Medical a private or public company?
Inquis Medical is a Private company.
-
What is the current valuation of Inquis Medical?
The current valuation of Inquis Medical is .
-
What is Inquis Medical’s current revenue?
The current revenue for Inquis Medical is .
-
How much funding has Inquis Medical raised over time?
Inquis Medical has raised $141M.
-
Who are Inquis Medical’s investors?
En Pointe, Marshall Wace, , , and Junson Capital are 5 of 8 investors who have invested in Inquis Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process